kabutan

Vector falls as Vitabrid’s fiscal 2027 outlook fails to spur buying

Tue Apr 14, 2026 2:14 pm JST Catalyst

Vitabrid Japan <542A> shares plunged on April 14, reversing a sharp rally in the previous session. The company reported record-high results for the fiscal year ended February 2026 after the market close on April 13, with sales rising 21.2% to 15.296 billion yen and operating profit jumping 45.8% to 1.022 billion yen. Growth was driven by the strong performance of its flagship "Terminalia First" supplement and successful product diversification.

Despite the record earnings, the stock was hit by profit-taking following a conservative outlook for the fiscal year ending February 2027. The company forecasts sales of 17.6 billion yen (up 15.1% year-on-year) and operating profit of 1.1 billion yen (up 7.6% year-on-year), with no dividend planned. Investors appeared disappointed by the projected slowdown in profit growth compared to the prior year’s surge.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.

Related Articles